Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Diluted Average) (2021 - 2025)

Roivant Sciences' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $686.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) fell 5.07% year-over-year to $686.1 million; the TTM value through Dec 2025 reached $686.1 million, down 5.07%, while the annual FY2025 figure was $725.4 million, 12.71% down from the prior year.
  • Shares Outstanding (Diluted Average) reached $686.1 million in Q4 2025 per ROIV's latest filing, up from $680.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $831.0 million in Q1 2024 to a low of $649.9 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $717.6 million, with a median of $703.1 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Diluted Average): rose 17.25% in 2023, then decreased 12.97% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $662.3 million in 2021, then increased by 6.16% to $703.1 million in 2022, then rose by 17.25% to $824.3 million in 2023, then fell by 12.32% to $722.7 million in 2024, then fell by 5.07% to $686.1 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Shares Outstanding (Diluted Average) are $686.1 million (Q4 2025), $680.6 million (Q3 2025), and $680.3 million (Q2 2025).